Posters

Goeppert
Delegate
Speaker
Dr Anne Goeppert
Senior Research Scientist
AstraZeneca
1 : Generation of Advanced Genetic Disease Models in Immune Cells
Chan
Poster Presenter
Dr Leo Chan
R&D Manager
Nexcelom Bioscience
2 : High-throughput detection of CRISPR Cas 9 gene editing efficiency, cell proliferation - viability, and monoclonality validation using Celigo Image Cytometer
Dyson
Delegate
Poster Presenter
Michael Dyson
CTO
IONTAS Ltd
3 : Antibody and TCR display in mammalian cells created Using CRISPR/Cas9 and TALE Nucleases
Fisher
Delegate
Poster Presenter
David Fisher
APS
AstraZeneca
4 : High-Throughput Generation of Knock-Out Cell Line Panels
G L
Poster Presenter
Mr BALASUBRAMANI G L
PhD student
JAWAHARLAL NEHRU UNIVERSITY
5 : Drug repurposing approach to target DNA gyrase from Mycobacterium tuberculosis
White
Delegate
Poster Presenter
Dr Carl White
Research Fellow
Nottingham University
6 : Measurement of ligand binding and internalisation of endogenous CXCR4 chemokine receptors using high affinity Nanoluciferase complementation and CRISPR/Cas9 genome engineering.
Rico Vidal
Poster Presenter
Miss Eva Rico Vidal
Molecular Biologist
University of Dundee
LinkedIn
7 : Drug target validation for neglected diseases using CRISPR precision editing
Stirnimann
Poster Presenter
Dr Christian Stirnimann
Head Theragnostics Discovery
ETH Z├╝rich
8 : High-throughput drug screening with advanced cell-based assays
Lagauzere
Poster Presenter
Dr Sandra Lagauzere
Product manager Viromer CRISPR
Lipocalyx GmbH (supplier of Cambridge Biosciences)
9 : Delivery of Cas gRNA RNP using the VIROMER platform
Mair
Delegate
Speaker
Dr Barbara Mair
Postdoctoral fellow
Donnelly Centre for Cellular and Biomolecular Research, University of Toronto
10 : CRISPR-on-a-chip: Interrogating genetic determinants of protein expression in human cells using microfluidics
joberty
Delegate
Poster Presenter
Mr Gerard joberty
Investigator
Cellzome, a GSK company
11 : A dual guide RNA-based strategy for efficient CRISPR gene editing of cell pools with low heterogeneity of edited allelesA New Poster Abstract
Harbottle
Delegate
Poster Presenter
Dr Jennifer Harbottle
Scientist (Gene Editing)
Oxford Genetics
LinkedIn
12 : The in(del)s and outs of automated CRISPR-Cas9 genome editing: A robust CRISPR-Cas9 pipeline for high throughput mammalian genome editing
Johannisson
Poster Presenter
Ms Jenny Johannisson
Product Manager
Takara Bio Europe AB
13 : Footprint-free gene editing using CRISPR/Cas9 and single-cell cloning of edited human iPS cell
Grzeszczuk
Poster Presenter
Dr Magdalena Grzeszczuk
Postdoctoral Fellow
AstraZeneca
14 : Understanding compensation mechanisms in the emergence of resistance to DDR inhibitors that target replication stress.
Mulvihill
Poster Presenter
Exhibitor
Mr Douglas Mulvihill
Marketing Manager
Oxford Genetics
LinkedIn
15 : The in(del)s and outs of automated CRISPR-Cas9 genome editing: A robust CRISPR-Cas9 pipeline for high throughput mammalian genome editing
Mulvihill
Poster Presenter
Exhibitor
Mr Douglas Mulvihill
Marketing Manager
Oxford Genetics
LinkedIn
16 : Optimised CRISPR vector systems and automated library construction technologies for high-throughput cell line engineering and screening applications
Petkovic
Poster Presenter
Dr Maja Petkovic
Product Manager
AMS Biotechnology (Europe)
17 : CRISPR based targeted insertion of A tracks for titratable control of gene expression
Kuenzel
Poster Presenter
Dr. Ulrike Kuenzel
Post-doc/Research Associate
Evotec
LinkedIn
18 : CRISPR platform at Evotec
Yeo
Delegate
Poster Presenter
Dr Marcus Yeo
CEO
DefiniGEN Limited
19 : Optimised iPSC hepatocyte models for non-alcoholic fatty liver disease (NAFLD). We have generated the I148M mutation of the NAFLD-implicated gene PNPLA3 in a WT iPSC line and differentiated the resultant line into human hepatocyte-like cells.
lejeune
Poster Presenter
Ms aurore lejeune
Field Application Scientist
Labcyte
20 : Optimising cell line generation with acoustic dispensing technology
Chen
Poster Presenter
Dr Yaoyao Chen
Scientist
STEMCELL Technologies
21 : Disease Modeling of Primary Microcephaly using Cerebral Organoids Generated from CDK5RAP2 CRISPR-Cas9 Gene Edited Human Pluripotent Stem Cells
Perera
Delegate
Poster Presenter
Mr Nirmal Perera
Field Application Scientist
LGC - ATCC
22 : Assessment of RAS-RAF-MAPK Pathway Perturbations and PD-L1 Expression in an Isogenic 3D Tissue-Culture Model of Drug-Resistant Melanoma
Escudero-Ibarz
Poster Presenter
Dr Leire Escudero-Ibarz
Senior Scientist
GSK
23 : Precision Gene Editing in iPSC-derived Macrophages for Early Drug Discovery
Jones
Poster Presenter
Dr Dylan Jones
Senior Scientist
Oxford Genetics
LinkedIn
24 : Pooled CRISPR Kinome Screening in Lung Cancer Cells
Parker-Manuel
Poster Presenter
Dr Richard Parker-Manuel
Group Leader
Oxford Genetics
25 : Optimised CRISPR vector systems and automated library construction technologies for high-throughput cell line engineering and screening applications.
Sim
Delegate
Poster Presenter
Alex Sim
President
ScreenIn3D
26 : A microfluidic technology to aid pharmaceutical research using 3D in vitro models of disease
Yeo
Poster Presenter
Dr Marcus Yeo
CEO
Definigen Ltd
27 : Optimised iPSC hepatocyte models for non-alcoholic fatty liver disease (NAFLD). We have generated the I148M mutation of the NAFLD-implicated gene PNPLA3 in a WT iPSC line and differentiated the resultant line into human hepatocyte-like cells.
Davoli
Delegate
Poster Presenter
Dr Serena Davoli
Senior Scientist
Sphere Fluidics
28 : A MICROFLUIDIC DESKTOP SYSTEM FOR AUTOMATED GENOME EDITING OF SINGLE CELLS
Login
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018